Safety and Efficacy of Selective Internal Radionuclide Therapy with <sup>90</sup>Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization.

Pharmaceuticals (Basel) · 2024 · PMC10819448 · PMID 38256934

Europe PMC DOI

hedged sentence

0.0070

closest p · 0.1× alpha

0.0070

boldest claim

The sentences

showed a trendp = 0.007actually significant

Patients developing grade II hepatotoxicity showed a trend towards a shorter survival (median OS, 7 months (95% CI, 6–8) versus 14 (95% CI, 11–17), p = 0.007, Figure 4 B).

also in 10,348 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.